Back to results
US 2020/0368177 A1Published application
Methods and compositions for treating neurological conditions
OwnerStuart A. LIPTONinventor
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for treating juvenile onset neurological conditions, such as autism (ASD), intellectual disability, or epilepsy, with an inhibitor of N-methyl-D-aspartate receptor (NMDAR). The inhibitor may be NitroSynapsin or a derivative thereof.
Claims31
A method of treating a juvenile-onset neurological condition in a subject in need thereof with an inhibitor of N-methyl-D-aspartate type of glutamate receptor (NMDAR).
Dependencies are inferred from the claim text.